TheraRadar
← Back
Data updated: Mar 29, 2026

NOVITIUM PHARMA

CardiovascularGastroenterologyImmunology
Generics

NOVITIUM PHARMA is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Immunology. Key products include INZIRQO.

1971
Since
97
Drugs
-
Trials
1014
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 28%
8 drugs
Gastroenterology 21%
6 drugs
Immunology 17%
5 drugs
Neurology 17%
5 drugs
Infectious Disease 17%
5 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...